Drug Trial Radar · NCT06911320
Study of Bemnifosbuvir/Ruzasvir as a Fixed-dose Combination in Subjects With Normal or Severely Impaired Renal or Hepatic Function
Last checked: Nov 20, 2026Latest source record: Jul 31, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
28
Actual
Start
Apr 9, 2025
Primary completion
Apr 30, 2026
Study completion Apr 30, 2026
Sponsor
- Lead sponsor
- Atea Pharmaceuticals, Inc.Industry
- Sponsor type
- Industry
- First posted
- Apr 4, 2025
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
To Assess the Effect of Severe Hepatic or Renal Impairment on the Pharmacokinetics of Bemnifosbuvir/Ruzasvir After a Single Dose
Conditions
- Healthy Volunteer Study
- Hepatic Impairment
- Renal Impairment
Interventions
Bemnifosbuvir (BEM)/Ruzasvir (RZR) as a fixed-dose combinationDrug
A single dose of BEM/RZR will be administered
Primary outcomes
What the sponsor says the trial is designed to measure.
- Pharmacokinetics (PK) of BEM/RZR Maximum plasma concentration (Cmax)Time frame: Day 1
- Pharmacokinetics (PK) of BEM/RZR Area under the plasma concentration-time curve (AUC)Time frame: Day 1
- Pharmacokinetics (PK) of BEM/RZR AUCTime frame: Day 1
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Atea Study Site
Orlando, Florida
Atea Study Site
Tampa, Florida
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.